Picodya Technologies

In Vitro Diagnostics (IVD) Platform

Health Tech & Life Sciences
Active
Series A , Israel Founded 2018
Last updated 2026-06-18
Total raised
$51.4M
Last: Grant 2024-01
Stage
Series A
Founded
2018
Headcount
31
HQ
, Israel
Sector
Health Tech & Life Sciences

About

Picodya introduces game-changing technology with the proven potential to empower diagnostics access worldwide.

Picodya's B-Matrix, microfluidic lab-on-a-chip platform redefines diagnostics, supports simultaneous hybrid testing for both molecular and immunoassays with multiplexed syndromic panels for various sample types. Its innovative multi-use consumables utilization allows for massive cost reduction while the minimal sample volume offers less invasive patients’ experience. The system unique and modular design supports diverse clinical settings anywhere from a large hospital systems’ laboratory through urgent care settings and physician offices as well as emerging settings such as airports, pharmacies and patients’ homes.

Funding history · 10 rounds · $51.4M total

2024-01
Grant $300K
2023-11
$7.5M
2023-02
Grant $1.2M
2022-11
Grant $300K
2021-11
$25.0M
2021-04
$10.0M
2020-04
Grant $400K
2019-08
Grant $700K
2018-05
Grant $1.3M
2018-01
$4.7M

Q&A

What is Picodya Technologies' primary focus?
Picodya Technologies is focused on In Vitro Diagnostics (IVD) Platform, specifically developing the B-Matrix, a microfluidic lab-on-a-chip platform for simultaneous hybrid testing of molecular and immunoassays.
When was Picodya Technologies founded?
Picodya Technologies was founded in February 2018.
What is the total amount of funding Picodya Technologies has raised to date?
Picodya Technologies has raised a total of $51,400,000 USD.
When was Picodya Technologies' most recent funding round and what type was it?
Picodya Technologies' most recent funding round was a Grant in January 2024, raising $300,000 USD.
How many employees does Picodya Technologies currently have?
Picodya Technologies has 11-50 employees.
Who are the co-founders of Picodya Technologies?
The co-founders of Picodya Technologies are Eli Ben Simon (Co-founder & Chairman), Tzvika Barkai (Co-founder & CEO), and Yehuda Yavets-Chen (Co-founder & CTO).
What is Picodya Technologies' current funding stage?
Picodya Technologies is currently in the Series A funding stage.
Does Picodya Technologies hold any patents?
Yes, Picodya Technologies holds one patent.

Team · 3

Founder · Co-founder & Chairman
LinkedIn ↗
Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportDigital Medical DiagnosticsMedical DevicesDiagnostics Devices
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratories
Business model
B2B

Highlights

1 PatentsVerified

Tags

bioconvergenceinfectious-diseasehome-caredigital-healthcareblood-testdiagnosticshospitalsartificial-intelligenceclinicsmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepicodya.com
LinkedInlinkedin.com/company/67241842

Identifiers & details

Founded2018-2
Employees (exact)31

Radar intelligence

Patents

EPO2

GitHub

Top reposEMATRIX, recogito-client-plugins

Web history (Wayback)

Domainpicodya.com

Certificate / subdomain footprint

Subdomains2